C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 237/28 (2006.01) A61K 31/502 (2006.01) A61P 3/10 (2006.01) C07D 403/04 (2006.01)
Patent
CA 2730059
Compounds of formula (I) as well as pharmaceutically acceptable salts and esters thereof, wherein A and R1 to R3 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.
L'invention porte sur des composés représentés par la formule (I), ainsi que sur des sels et esters pharmaceutiquement acceptables correspondants, dans laquelle formule A et R1 à R3 présentent la signification donnée dans la revendication 1 et peuvent être utilisés sous la forme de compositions pharmaceutiques.
Ackermann Jean
Amrein Kurt
Kuhn Bernd
Mayweg Alexander V.
Neidhart Werner
F.hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Tetrahydrocinnolines as 11 beta hsd1 inhibitors for diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydrocinnolines as 11 beta hsd1 inhibitors for diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydrocinnolines as 11 beta hsd1 inhibitors for diabetes will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1575734